Paragon 28 (FNA) to Release Earnings on Wednesday

Paragon 28 (NYSE:FNA) is expected to release its Q1 2025 earnings data before the market opens on Wednesday, May 14th. Analysts expect Paragon 28 to post earnings of ($0.19) per share and revenue of $69.62 million for the quarter.

Paragon 28 (NYSE:FNA) last announced its quarterly earnings data on Thursday, March 6th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.01). The firm had revenue of $71.75 million for the quarter, compared to analysts’ expectations of $70.81 million. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. On average, analysts expect Paragon 28 to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Paragon 28 Price Performance

FNA opened at $13.11 on Monday. The stock has a 50-day moving average price of $13.05 and a 200-day moving average price of $11.42. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60. The firm has a market cap of $1.10 billion, a PE ratio of -17.71 and a beta of 1.47. Paragon 28 has a 1 year low of $4.65 and a 1 year high of $13.13.

Insider Buying and Selling

In related news, major shareholder Mvm Partners, Llc sold 1,044,295 shares of Paragon 28 stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $13.04, for a total value of $13,617,606.80. Following the completion of the sale, the insider now directly owns 7,810,588 shares in the company, valued at approximately $101,850,067.52. This trade represents a 11.79% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last ninety days, insiders sold 1,828,706 shares of company stock worth $23,810,399. 15.32% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on FNA. William Blair lowered Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Stephens reaffirmed an “equal weight” rating and issued a $13.00 price target (down previously from $14.00) on shares of Paragon 28 in a research report on Thursday, January 30th. Canaccord Genuity Group set a $13.00 price target on Paragon 28 in a research report on Wednesday, January 29th. Finally, Needham & Company LLC reaffirmed a “hold” rating and issued a $13.00 price target on shares of Paragon 28 in a research report on Wednesday, January 29th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, Paragon 28 presently has an average rating of “Hold” and a consensus price target of $12.75.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.